Over the past years, media coverage of firms has received significant scholarly attention. However, the resulting literature is spread across multiple disciplines and, therefore, varies with regard to its theoretical underpinnings and contextual settings. This makes it challenging for scholars to understand the contributions of this literature, to identify areas of inquiry, and to develop an encompassing research agenda. In this review, we address these issues by surveying the diverse literature on media coverage of firms to develop an integrative framework of the antecedents and consequences of media coverage that highlights paths for future research. Specifically, we identify the three theoretical perspectives—economic, institutional, and social-psychological—that the literature generally assumes on the news media. In addition, we highlight differences between strategy, finance, governance, and crisis contexts and review results from articles examining media coverage of firms in aggregate. In each context, we identify the primary functions of the news media as well as antecedents and consequences of media coverage. We proceed to develop an integrative framework for media coverage of firms by building on these findings and by examining the empirical methods used to measure media coverage, particularly regarding the measurement of specific coverage attributes. We highlight the gaps in current knowledge that our framework exposes and derive opportunities for future research that can further scholars’ and practitioners’ understanding of firm media coverage.
We study how the cognitive complexity of chief executive officers (CEOs) changes during their tenures. Drawing from prior theory and research, we argue that CEOs attain gradually greater role-specific knowledge, or expertise, as their tenures advance, which yields more complex thinking. Beyond examining the main effect of CEO tenure on cognitive complexity, we consider three moderators of this relationship, each of which is expected to influence the accumulation of expertise over a CEO’s time in office: industry dynamism, industry jolts, and CEO positional power. We conduct our tests on a sample of 684 CEOs of public corporations. The analytic centerpiece of our study is a novel index of CEO cognitive complexity based on CEOs’ language patterns in the question-and-answer portions of quarterly conference calls. As part of our extensive theory of measurement, we provide evidence of the reliability and validity of our index. Our results indicate that CEOs, in general, experience substantial increases in cognitive complexity over their time in office. Examined moderators somewhat, but modestly, alter this general trajectory, and nonlinearities are not observed. We discuss the implications of our findings.
This study reports early evidence of managers' mental health and its predictors during the Coronavirus disease 2019 (COVID-19) pandemic in May 2020. In a sample of 646 managers from 49 countries, 5.3% (32) of managers reached the cutoff levels for disorders in distress (Kessler Psychological Distress Scale-6; K-6), 7.3% (38) experienced anxiety (General Anxiety Disorder-7; GAD-7), and 10.7% (56) had depression (Patient Health Questionnaire-9; PHQ-9). Age, relative income, and work status each predicted at least one of the conditions. Managers' 'illegitimate tasks' caused by COVID-19 predicted all three. Particularly noteworthy is the finding that the degree of downsizing an organization experienced during COVID-19 significantly predicted distress, anxiety, and depression for managers at the highest level (board members) only. This study helps identify managers in need of healthcare services as the COVID-19 pandemic affects organizations and their managers around the world.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.